Search Results

Bioz, Inc., a leading Silicon Valley based AI software company committed to empowering scientists towards optimal scientific discovery, is delighted to announce its partnership with CE Elantech.

Zomedica Corp. announced it has secured the CE mark for its proprietary point-of-care TRUFORMA Bulk Acoustic Wave diagnostic platform.

MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlow LibertyTM Transcatheter Aortic Valve and Retrievable Delivery System (VitaFlow LibertyTM), has received EU CE-MDR certification.

AngioDynamics, Inc. (NASDAQ: ANGO) today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary arteries and for the treatment of pulmonary embolism (PE).

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation regulatory framework.

Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation 20147/745, for its state-of-the-art Aveta Hysteroscopy System.

Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, announced that it has received CE certification for its VetGuardian® remote contactless monitoring system.

Femasys, Inc., a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it has received its European Union Medical Device Regulation certificate and CE Mark certification for four of its products.

RDS, the medical device start-up, today announces the granting of the CE mark for MultiSense®, its patented, wearable solution for continuous Remote Patient Monitoring.

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that the Axonics R20™ rechargeable sacral neuromodulation system has received CE Mark approval.